NOS2 and cancer: Since breast tumors, differently from other cancer types, more rarely harbor Ras mutations (77), the S-nitrosylation of Ras and thus the activation of Ets1 signaling axis may indeed explain the wild-type Ras-mediated tumorigenesis of cancers overexpressing NOS2.